IQVIA Holdings
- Market cap
- 42.48B
- P/E (TTM)i
- 32.10
- P/Bi
- 6.88
- EPSi
- 7.84
- Div yieldi
- 0.00%
- 52W posi
- 84%
Anonymous reader poll. Unscientific, not investment advice.
About IQVIA Holdings
IQVIA Holdings, Inc. engages in the provision of analytics, technology solutions, and clinical research services to the life sciences industry. It operates through the following segments: Technology and Analytics Solutions, Research and Development Solutions, and Contract Sales and Medical Solutions. The Technology and Analytics Solutions segment supplies mission-critical information, technology solutions, and real-world evidence services to the company's life sciences clients. The Research and Development Solutions segment provides outsourced clinical research and clinical trial-related services. The Contract Sales and Medical Solutions segment offers healthcare provider and patient engagement services to both biopharmaceutical customers and the broader healthcare market. The company was founded by Dennis B. Gillings and Gary Koch in 1950 and is headquartered in Durham, NC.
- Founded
- 1950
- CEO
- Mr. Ari Bousbib
- Employees
- 93,000
- Headquarters
- Durham, North Carolina, United States of America
- Fiscal year end
- 12-31
- Website
- iqvia.com
Company profile
- Exchange
- US
- Symbol
- IQV
- Market-cap rank
- #493
- Listing date
- 1970-01-01
- Market cap
- 42.48B
- Float cap
- 40.33B
- Shares out
- 164.60M
- Float shares
- 156.25M
Sectors & themes
Quote time 2026-10-08 04:32:15 · For reference only, not investment advice and not tailored to your situation.